Search - tctmd.com

Displaying 221 - 240 of 3110

Sort: Relevancy | Date

Presentation TCT 2023

TCT 62: Prognosis After Non-Infarct Related Artery PCI in Patients with Acute Myocardial Infarction and Multivessel Disease

Presenter: Seung Hun Lee

October 26, 2023

Presentation TCT 2023

Coronary Keynote Lecture: My Personal Guide to Prevention and Management of Primary PCI Complications

Presenter: Dariusz Dudek

October 26, 2023

Presentation TCT 2023

Pharmacology for STEMI PCI: Which Therapies Before, Options During the Case, and Management Post

Presenter: Sonya Burgess

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

Reperfusion of the Infarct Related Artery With Timely Primary PCI

Presenter: Cindy Grines

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Case Resolution: Long-term Therapy

Presenter: NULL

October 25, 2023

Presentation TCT 2023

The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient

Presenter: John Bittl

October 25, 2023

Presentation TCT 2023

Longer Term DAPT Is What The Guidelines and Data Support

Presenter: Mamas Mamas

October 25, 2023

Presentation TCT 2023

Case Continuation: In Hospital Management

Presenter: Davide Cao

October 25, 2023

Presentation TCT 2023

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Presenter: Michael Savage

October 25, 2023

Presentation TCT 2023

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Presenter: Jennifer Rymer

October 25, 2023

$Unfractionated Heparin Still Works for Primary PCI!$

Presentation TCT 2023

Unfractionated Heparin Still Works for Primary PCI!

Presenter: Rod Stables

October 25, 2023

Presentation TCT 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presenter: Gregg Stone

October 25, 2023

Presentation TCT 2023

Case Presentation

Presenter: Davide Cao

October 25, 2023

Presentation TCT 2023

TCT 44: P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study

Presenter: Seung-Yul Lee

October 24, 2023

Presentation TCT 2023

TCT 136: Optical Frequency Domain Imaging vs. Intravascular Ultrasound in Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Primary Result From the OPINION ACS Trial

Presenter: Hiromasa Otake

October 24, 2023

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

Presentation TCT 2023

Case 3 – Complex Calcified Left Main Bifurcation in a Patient in Cardiogenic Shock

Presenter: Balbir Singh

October 23, 2023

Advertisement

TCT 62: Prognosis After Non-Infarct Related Artery PCI in Patients with Acute Myocardial Infarction and Multivessel Disease

Coronary Keynote Lecture: My Personal Guide to Prevention and Management of Primary PCI Complications

Pharmacology for STEMI PCI: Which Therapies Before, Options During the Case, and Management Post

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Reperfusion of the Infarct Related Artery With Timely Primary PCI

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Case Resolution: Long-term Therapy

The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient

Longer Term DAPT Is What The Guidelines and Data Support

Case Continuation: In Hospital Management

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Unfractionated Heparin Still Works for Primary PCI!

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Case Presentation

TCT 44: P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study

TCT 136: Optical Frequency Domain Imaging vs. Intravascular Ultrasound in Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Primary Result From the OPINION ACS Trial

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Case 3 – Complex Calcified Left Main Bifurcation in a Patient in Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content